Interpretation and Reporting in Obstructive Coronary Disease

Published on 24/02/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1855 times

CHAPTER 35 Interpretation and Reporting in Obstructive Coronary Disease

Since its introduction in the early 1970s, computed tomography (CT) has become a well-established imaging technology and the modality of choice for noninvasive evaluation of the aorta and pulmonary, carotid, renal, and peripheral arteries.

In CT angiography (CTA), the use of rapidly injected contrast agents raises the density in the blood pool, thereby allowing easy differentiation between the lumen, vessel walls, and surrounding tissues.

CT imaging of the coronary arteries became practical with the arrival of the 4-slice scanners. The ongoing advancement and innovation in CT technology over the years provided faster scans with improved temporal and spatial resolutions. As a result, the role of CT in the imaging of coronary arteries progressed from simple determination of the presence of arterial calcifications to demonstration of the atherosclerotic plaque itself and quantification of luminal stenoses.

DESCRIPTION OF TECHNICAL REQUIREMENTS

Challenges in noninvasive cardiac imaging by CT include small (typically 1 to 4 mm) and often tortuous vessels, complex and rapid cardiac motion, and variable, often unpredictable heart rates and respiratory motion. As a result, all cardiac scans are performed with ECG gating, either prospective or retrospective, to allow reconstruction of motion-free images.

CT scans of the heart should be fast and performed during a single, preferably short breath-hold to avoid breathing artifacts and to allow minimal contrast agent volume. Sub-second rotation time resulting in high temporal resolution is required to eliminate cardiac motion. High spatial resolution, preferably sub-millimeter, is necessary to adequately visualize small and complex anatomic structures such as the coronary arteries.

Adequate preparation of the patient is a must, and therefore a team made up of scheduling staff, technologist, physician, and nurse is required. Documentation of serum creatinine level and history of contrast allergy is essential at the time of scheduling. The risk of contrast nephropathy must be weighed against the benefits of the information gained by the procedure. Depending on the clinical indication, some degree of renal protection may be achieved with good hydration before and after injection of contrast material as well as the administration of N-acetylcysteine. In case of a known allergy to contrast material, and if the risk is acceptable to both patient and referring physician, pretreatment with corticosteroids may prevent reaction to the contrast agent.

The coronary arteries are best demonstrated when there is the least amount of motion. There are two relatively motionless phases during the cardiac cycle: diastasis in late diastole and isovolumic relaxation time in late systole. The diastasis period is longer; but at higher heart rates, it is almost eliminated. Isovolumic relaxation time, on the other hand, is shorter but unaffected by heart rate.

Lowering of the patient’s heart rate is suggested on the basis of comparison of coronary artery visibility in patients with low versus high heart rates. Most studies so far have been performed on 4-, 16-, and 64-slice scanners and have shown a higher number of unassessable segments in patients with rapid heart rates compared with patients with lower heart rates. Furthermore, a low heart rate, with a longer cardiac cycle, enables the use of tube current modulation (with full x-ray output only during a fixed period in diastole), thus reducing radiation dose. Preliminary experience with the latest generation of scanners (more than 64-slice and dual-source units) with improved temporal resolution shows promising results in patients with higher heart rates.

Heart rate can be controlled through the use of medication (e.g., oral or intravenous β blockers), by reassuring the patient (i.e., explaining the procedure, describing what to expect), and by rehearsing the breath-hold required during the scan. Practicing the breath-hold is also important to anticipate heart rate changes that may occur during the scan.

Sublingual nitroglycerin (if it is not contraindicated) should be administered immediately before the scan is started to improve vessel visualization. This is particularly important in women, smokers, diabetics, and patients who have had bypass graft surgery.

The radiation dose should be as low as possible with parameters adjusted to the patient’s size and expected heart rate for optimal visualization. In very large patients, a lower pitch should be considered to allow increased radiation dose.

TECHNIQUES

Indications

In recent years, technologic advancements have improved the temporal and spatial resolution of scanners as well as reduced acquisition time, resulting in reliable assessments of the heart and coronary arteries.

Potential indications for coronary CTA are many and continue to evolve. Recently, the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, the American College of Radiology, and others have published a joint review on the appropriateness of cardiac CTA.1 This report scored the appropriateness of cardiac CTA in several clinical applications on a scale from 1 to 9 based on the available literature. The information and experience available with cardiac CTA at this time are not robust enough to support categorical recommendations and guidelines. This is so because the technology continues to change rapidly, there are not enough prospective studies on different groups of patients, and there are no outcome studies on the prognostic value of cardiac CTA. Therefore, the appropriateness criteria are not guidelines but rather temporary recommendations until official guidelines are published.

Among the potential indications for cardiac CTA, there are four clinical groups. The first group includes patients with an indication for invasive catheterization when the procedure is anticipated to be technically demanding (e.g., ascending aortic aneurysm, atherosclerotic arch, anticoagulant therapy), patients with a prior incomplete catheterization, and patients with suspected coronary anomalies. For patients in this group, cardiac CTA may be the optimal imaging modality and in certain cases the only one.

The second group consists of patients with an intermediate pretest probability for obstructive coronary artery disease. This includes patients with atypical symptoms, acute chest pain of uncertain origin, and inconclusive stress test or thallium scan as well as candidates for valve or noncardiac surgery. The purpose of cardiac CTA in this group is to exclude significant coronary stenosis, and a normal scan may obviate the need for a catheter-based intervention.

The third group includes patients with known coronary artery disease (e.g., patients after stent placement or bypass grafting) who present with a specific question, such as stent or graft patency. This group of patients tends to have frequent complaints; traditional noninvasive tests have limited predictive accuracy, and invasive procedures are commonly employed. Here, exclusion of significant stenosis may prevent unnecessary catheter-based intervention.

The fourth group is controversial and consists of asymptomatic individuals at risk for coronary artery disease. On the one hand, CT is able to identify subclinical atherosclerosis, and the findings themselves may lead to improved compliance with preventive regimens. On the other hand, CTA involves administration of contrast material and radiation exposure, and we currently have not established an approach to dealing with such findings.

Pitfalls and Solutions

In CT, the term artifact applies to any systematic discrepancy between the CT numbers in the reconstructed image and the true attenuation coefficients of the object. CT images are inherently prone to artifacts because the image is reconstructed from multiple independent detector measurements. The reconstruction algorithm assumes that all these measurements are consistent, so any error of measurement will usually be reflected as an error in the reconstructed image.2,3

Four types of artifact can occur: streaking, due to an inconsistency in a single measurement; shading, due to a group of channels or views deviating gradually from the true measurement; rings, which are due to errors in an individual detector calibration; and distortion, due to the helical reconstruction.

Artifacts can seriously degrade the quality of CT images, sometimes to the point of making them diagnostically unusable. Furthermore, accuracy of cardiac CTA for detection of stenoses depends highly on image artifacts,3 which are a major cause of false-positive and false-negative interpretations.

To optimize image quality, it is necessary to understand why artifacts occur and how they can be prevented (Table 35-1). CT artifacts originate from a range of sources. Physics-based artifacts result from the physical processes involved in the acquisition of CT data. Patient-based artifacts are caused by such factors as movement of the patient or the presence of metallic materials inside or on the patient.

Careful preparation of the patient and optimum selection of scanning parameters are, therefore, important factors in avoiding CT artifacts.

Stair-Step Artifacts

Stair-step artifacts appear as horizontal lines through the image, visible especially around the edges of structures in multiplanar and three-dimensional reformatted images, when wide collimations and non-overlapping reconstruction intervals are used. They are less severe with helical scanning, which permits reconstruction of overlapping sections without the extra dose to the patient that would occur if overlapping axial scans were obtained. Stair-step artifacts are virtually eliminated in multiplanar and three-dimensional reformatted images from thin-section data obtained with today’s multisection scanners.

In ECG-gated scans, an irregular R–R interval may cause data inconsistencies that are not recognized by the reconstruction algorithm, resulting in stair-step artifacts through the heart (Fig. 35-8).

Administration of β blockers to lower the heart rate and to try to stabilize it may prevent arrhythmia during the scan. Some manufacturers provide software for R-tag correction in case an arrhythmia has occurred (Fig. 35-9). Looking for a quiet phase of the cardiac cycle with minimal motion may help minimize cardiac motion–induced artifacts. If prospective gating with sequential (axial) acquisition mode is used, heart rate changes during the scan cause stair-step artifacts through the volume (Fig. 35-10).

Image Interpretation

Postprocessing

Images can be reconstructed during different cardiac phases, allowing retrospective selection of the phase with the least motion artifacts.

For easier evaluation of the large amount of CT data and the complex anatomy of the coronary arteries, several postprocessing techniques are available. Image postprocessing requires modification of three-dimensional data to derive additional information or to hide unwanted information. The isotropic sub-millimeter voxel, available in all advanced scanners, improves the diagnostic quality of rendered images. Analysis of rendered images as well as of the axial slices has become a crucial component of cardiac CTA interpretation.

Multiplanar Reformation

In multiplanar reformation (MPR), a plane is defined within the three-dimensional volume of the scan, and only the data in this plane are displayed. MPR can be performed in either a straight plane or a curved plane (along a vessel’s “centerline”). In performing MPR, the thickness of the selection is set to be as thin as the collimation allows. When a greater thickness is selected, a slab MPR is created, and it is usually rendered with maximum intensity projection (see later). MPR can be created in any plane; it is very fast and easy to use and provides images containing all available information (all Hounsfield unit values are retained). Curved MPR with cross-sectional images is the best method for stenosis assessment, particularly in patients with calcified lesions or stents (Fig. 35-11). It is possible to rotate the image around the centerline and to view any plaque from different rotational angles to differentiate between eccentric and concentric plaques. A major disadvantage of MPR is the dependence on manual orientation of the planes that may cause false-positive or false-negative interpretation of stenoses. Interactive viewing of these types of images from multiple viewing angles is therefore required. Furthermore, for each vessel branch, a separate MPR image is required, and only one branch can be displayed at a time. Advanced software is available to allow semiautomatic segmentation of the coronary arteries, to determine the vessel’s centerline, and to reconstruct curved MPR as well as cross-sectional images.

Stenosis Assessment

The rapid evolution of multidetector CT (MDCT) technology has revolutionized cardiac CT, previously limited by cardiac motion, slow acquisition times, and insufficient resolution. Image quality and diagnostic performance have greatly improved with recent technical advances. Many studies have compared MDCT (4-,16-, and 64-slice scanners) with invasive coronary angiography in the assessment of coronary artery narrowing.

The percentage of unassessable segments was more than 30% on a 4-slice scanner4,5 and around 22% to 29% with 16-slice scanners.6,7 One study stated that if these unassessable segments were excluded or considered negative, 25% of patients with a significant stenosis would have been missed.7 With 64-MDCT, only 3% to 11% of coronary artery segments still cannot be evaluated.811

Sensitivities and specificities for detection of significant (>50%) coronary artery stenoses based on segmental analysis with 64-MDCT (with conventional x-ray coronary angiography as the standard of reference) have been found to be good to excellent, in the range of 76% to 99% and 95% to 97%, respectively.1115 However, these study outcomes are difficult to compare, mainly because of the different selection of patients and the prevalence of significant coronary artery disease. Moreover, these study results should be interpreted with care because of exclusion of unassessable segments from analysis as well as studies with reduced image quality. In an unselected population of patients referred for coronary catheterization with a high prevalence of risk factors, we found high specificity (95%) and negative predictive value (95%) and moderate sensitivity (72%) for significant coronary narrowing with use of a 40-slice scanner.16 All studies found that cardiac CTA has a very high negative predictive value (95% or higher) for exclusion of significant coronary stenosis.

Accuracy for detection of stenoses depends highly on image quality and artifacts. False-positive and false-negative interpretations were attributed to image artifacts in 91% to 100% of cases,10,1214,17,18 mainly because of the presence of calcifications. Less frequent causes were motion artifacts and obesity, resulting in a poor contrast-to-noise ratio.

As mentioned, calcified plaques are a major cause of overestimation of stenosis, mainly with the older generation of scanners (4- and 16-slice scanners). It was recommended to perform a non–contrast-enhanced scan before the cardiac CTA and to avoid scanning patients with high calcium scores (usually above 400 to 600). In our experience, using the 64-slice scanner, with improved temporal and spatial resolution, it is possible to cope with most calcified plaques. Curved MPR with cross-sectional images through the plaque is the method of choice (Fig. 35-12). If a lumen is visible adjacent to a calcification (regardless of its size), significant stenosis (>50%) can be excluded.

Plaque Characterization

Acute coronary events are usually caused by rupture of atherosclerotic plaque (in most cases, nonobstructive plaque), platelet aggregation, and thrombosis with partial or complete occlusion of the arterial lumen. This is one of the reasons that many patients do not have symptoms before their first coronary event. When individuals at increased risk for acute coronary events are identified while still asymptomatic, initiation of preventive therapy, including antiplatelet, antihypertensive, and lipid-lowering medications as indicated, can substantially reduce the risk of coronary artery events. Traditionally, the classic risk factors have been used to identify individuals at risk (quantification of their risk by the Framingham score), but they have limited predictive accuracy. Cardiac CTA is a noninvasive imaging modality allowing identification, quantification, and to some extent characterization of the atherosclerotic process at a subclinical stage. Quantification of coronary calcium (calcium scoring) is an established method to estimate the coronary plaque burden, with a high predictive value for occurrence of future cardiac events in asymptomatic individuals, independently of the traditional risk factors.19 However, the calcium score (calcified plaques) represents only about 20% of the total plaque burden,20 and it is the noncalcified component of the plaque that is considered less stable and prone to rupture.

In its early stages, atherosclerotic plaque is usually accompanied by an outward growth of the vessel (termed positive remodeling), indicating a large plaque volume without lumen narrowing. Invasive coronary angiography, the clinical “gold standard” for coronary artery imaging, allows visualization of the lumen only and therefore is not suitable for plaque imaging. Intravascular ultrasound (IVUS) is considered the method of choice for plaque visualization. However, this is a highly invasive and expensive modality, therefore unsuitable for routine use and risk stratification. Cardiac CTA is a noninvasive modality, widely available, that enables visualization of both vessel wall and lumen.

The ability of CT to identify and to characterize nonobstructive plaque composition (calcified, noncalcified, and mixed) has been demonstrated before,21,22 and Achenbach and coworkers23 demonstrated vessel wall remodeling in high-quality 16-slice scans. Schroeder and associates24 studied 12 patients and found that “hypoechoic” plaques on IVUS had a lower mean CT attenuation (14 ± 26 HU) compared with “fibrotic” plaques (91 ± 21 HU) or “calcified” plaques (419 ± 194 HU). Leber and colleagues25 found a mean density of 49 ± 22 HU for soft plaque, 91 ± 226 HU for intermediate (fibrous) plaque, and 391 ± 156 HU for calcified plaque, as defined by IVUS. Even though CT is able to detect a variety of densities within the plaque, in our experience and that of others, there is substantial overlap between those groups. Furthermore, contrast enhancement within the vessel lumen may affect plaque enhancement, leading to variability in readings for any given plaque.

Comparing the performance of the 64-slice scanner with IVUS for noncalcified plaque detection, Leber and colleagues26 found 84% sensitivity and 91% specificity, with good correlation between plaque and lumen area measured, especially in proximal segments of the coronary tree. Caussin and associates27 found that 16-detector row CT can accurately assess certain vulnerable plaque characteristics, such as hypodense areas (representing lipid), eccentricity, arterial remodeling, and calcifications, in comparison to IVUS. However, detailed microanatomy and detection of inflammatory changes in unstable lesions are beyond the resolution of current CT scanners.

We compared the total coronary plaque burden (segmental analysis), visualized by cardiac CT, with the traditional risk factors in 97 patients who underwent invasive coronary angiography. We found that nonobstructive coronary plaques were better detected on cardiac CT (277 of 737) than on invasive coronary angiography (111 of 737). The overall plaque burden was significantly higher in patients with diabetes, hypertension, or longer history of coronary artery disease and correlated with the number of risk factors. Furthermore, we found that among symptomatic patients without evidence of calcifications in the coronary arteries, 20% had noncalcified plaques and 7% had significant stenosis on 64-slice cardiac CT.28 Because the long-term prognostic significance of these findings is currently unknown, additional experience and especially follow-up are needed to determine whether the additional “effort” (radiation, contrast material, time) to detect noncalcified plaques is justified.

Reporting

A CTA report should be useful for the referring physician. It should begin with patient identification data and a brief clinical history as well as the indication for the current study. Next, a brief description of the procedural technique should be mentioned, including the type of scanner, type of contrast material and volume used, premedications (if given), and radiation dose.

Because the accuracy of cardiac CTA depends directly on image quality, it is very important to record the quality of the scan so that the referring physician will be able to assess its reliability. Address these questions: Is the scan assessable and reliable? What are the limitations of the scans? What are the reasons for artifacts? It is easy to answer these questions by a quick leaf through the axial slices or slab maximum intensity projection images of the best phase. If multiple phases are loaded, loop through all of them to choose the best phase and to assess integrity of the data. Changing into a “lung window” can help detect breathing artifacts. It is possible to look at the chest wall and cardiac margins in MPR or volume rendering techniques to assess for motion and stair-step artifacts. Assessment for cardiac motion is easier on an oblique MPR through the right coronary artery and circumflex artery, which are more susceptible to motion. If cardiac motion is detected, additional phases should be reconstructed, trying to find a motion-free phase (if the technologist is not trained to perform this assessment and to look for the best phase for the reader). Looking at the patient’s ECG can help detect arrhythmia or heart rate changes during the scan and prompt an R-tag correction if necessary and if software is available. Comment about each unassessable segment (including location and reason). In a coronal MPR, it is easy to assess contrast density and uniformity throughout the aorta and coronary tree as well as noise level within the scan.

Report the calcium score level (if performed) and its clinical significance for the patient’s gender and age. In the presence of a zero calcium score, even if the cardiac CTA quality is not optimal, the referring physician can be reassured of the very low likelihood of significant stenosis in a stable patient.

The next step is to report on each of the coronary artery segments visible (Fig. 35-13). Invasive angiography will usually visualize more distal segments than is possible with CTA, but vessels smaller than 1.5 mm are currently not suitable for an intervention (with stent placement or bypass grafting) anyway.

After the initial navigation with slab maximum intensity projection images to locate areas of suspected stenosis, we perform a curved MPR for each coronary artery and for each visible branch. Because CTA provides three-dimensional information, the view that shows the largest lumen is the correct one (Fig. 35-14). Invasive angiography, on the other hand, is a two-dimensional imaging modality that provides projections of the coronary tree, in which the tightest view is the correct answer. Therefore, it is important to look at every segment from different viewing angles (by rotating the MPR around the centerline) to appreciate correct lumen size. Plaques (especially calcified plaques) should be carefully evaluated in cross-sectional images to assess for a visible lumen adjacent to the calcification. Any abnormality should be confirmed in more than one phase to exclude artifacts.

Considering the spatial resolution of current scanners in relation to the size of the coronary arteries, in addition to the fact that cardiac motion may be reduced but not eliminated completely, cardiac CT cannot be expected to accurately quantify stenosis. Instead, cardiac CT should be used as a “filter” for patients with suspected coronary stenosis before invasive procedures.

For each lesion, it is important to indicate location (ostial, proximal, mid or distal, relation to branches), composition (noncalcified, mixed, or calcified plaque), eccentric or concentric, and evidence of remodeling.

Instead of giving precise stenosis percentage, we prefer to categorize each lesion into groups according to suspected severity of stenosis and clinical relevance (Table 35-2). Our categories include normal (when the vessel is smooth and there is no evidence of plaque), nonsignificant or mild stenosis (when there is some irregularity or plaques causing up to 40% stenosis), borderline lesions (when a lesion is suspected to cause 40% to 60% stenosis), and significant stenosis (when a lesion is suspected to cause more than 70% stenosis up to total occlusion). Alternatively, quartile gradations can be used, such as 0% to 25%, 26% to 50%, 51% to 75%, and 76% to 100%. Remember to underestimate stenosis caused by a calcified plaque (because of the blooming effect), and as long as a lumen is visible, significant stenosis can safely be excluded. The term total occlusion should be used only when no contrast material is visible distal to a stenosis because it is not possible to differentiate on CTA between antegrade and retrograde filling of a segment (Fig. 35-15). It is important to comment on presence of calcifications within the occluded segment, indicating chronic or acute on chronic lesion, which may be more difficult to treat invasively. When a lesion is difficult to assess (because of artifacts or calcifications), use of a statement such as “stenosis cannot be excluded” may be reasonable.

After the findings and limitations based on scan quality are summarized, it is important to try to answer the questions that the referring physician is asking and to end with reasonable recommendations for the next step.

By dividing the lesions into the mentioned categories, it is easier for the referring physician to decide about the next step that needs to be taken. When the vessels are normal, this implies that no evidence of atherosclerosis is found. With mild stenosis, only preventive medical treatment is required to prevent future coronary events. In borderline lesions, it is clear that further investigation is needed, usually with a noninvasive functional test (myocardial perfusion scan or stress echocardiography). When a patient has obstructive coronary artery disease, an invasive procedure may be warranted for confirmation of stenosis severity and treatment (particularly if it is accompanied by symptoms and significant reversible perfusion defects on functional testing).

KEY POINTS

REFERENCES

1 Hendel RC, Patel MR, Kramer CM, Poon M. ACCF/ARC/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475-1497.

2 Barrett JF, Keat N. Artifacts in CT: recognition and avoidance. Radiographics. 2004;24:1679-1691.

3 Kroft LJM, de Roos A, Geleijns J. Artifacts in ECG-synchronized MDCT coronary angiography. AJR Am J Roentgenol. 2007;189:581-591.

4 Giesler T, Baum U, Ropers D, et al. Noninvasive visualization of coronary arteries using contrast-enhanced multidetector CT: influence of heart rate on image quality and stenosis detection. AJR Am J Roentgenol. 2002;179:911-916.

5 Nieman K, Rensing BJ, van Geuns RJ, et al. Usefulness of multislice computed tomography for detecting obstructive coronary artery disease. Am J Cardiol. 2002;89:913-918.

6 Heuschmid M, Kuettner A, Schroeder S, et al. ECG-gated 16-MDCT of the coronary arteries: assessment of image quality and accuracy in detecting stenosis. AJR Am J Roentgenol. 2005;184:1413-1419.

7 Garcia MJ, Lessick J, Hoffmann MHK. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006;296:403-411.

8 Ferencik M, Nomura CH, Maurovich-Horvat P, et al. Quantitative parameters of image quality in 64-slice computed tomography angiography of the coronary arteries. Eur J Radiol. 2006;57:373-379.

9 Pannu HK, Jacobs JE, Lai S, Fishman EK. Coronary CT angiography with 64-MDCT: assessment of vessel visibility. AJR Am J Roentgenol. 2006;187:119-126.

10 Leshka S, Husmann L, Desbiolles LM, et al. Optimal image reconstruction intervals for non-invasive coronary angiography with 64-slice CT. Eur Radiol. 2006;16:1964-1972.

11 Nikolaou K, Knez A, Rist C, et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. AJR Am J Roentgenol. 2006;187:111-117.

12 Mollet NR, Cademartiri F, van Mieghem CAG, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005;112:2318-2323.

13 Leber AW, Knez A, von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147-154.

14 Raff GL, Gallagher MJ, O’Neill WW, Goldstein JA. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol. 2005;46:552-557.

15 Pugliese F, Mollet NRA, Runza G, et al. Diagnostic accuracy of non-invasive 64-slice CT coronary angiography in patients with stable angina pectoris. Eur Radiol. 2006;16:575-582.

16 Halon DA, Gaspar T, Adawi S, et al. Uses and limitations of 40 slice multi-detector row spiral computed tomography for diagnosing coronary lesions in unselected patients referred for routine invasive coronary angiography. Cardiology. 2006;108:200-209.

17 Leschka S, Alkadhi H, Plass A, et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J. 2005;26:1482-1487.

18 Ropers D, Rixe J, Anders K, et al. Usefulness of multidetector row spiral computed tomography with 64- × 0.6-mm collimation and 330-ms rotation for the non-invasive detection of significant coronary artery stenoses. Am J Cardiol. 2006;97:343-348.

19 Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826-833.

20 Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;92:2157-2162.

21 Achenbach S, Moselewski F, Ropers D, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography. A segment-based comparison with intravascular ultrasound. Circulation. 2004;109:14-17.

22 Schoenhagen P, Tuzcu EM, Stillman AE, et al. Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: comparison of 16-slice computed tomography and intravascular ultrasound. Coron Artery Dis. 2003;14:459-462.

23 Achenbach S, Ropers D, Hoffmann U, et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol. 2004;43:842-847.

24 Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol. 2001;37:1430-1435.

25 Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques. J Am Coll Cardiol. 2004;43:1241-1247.

26 Leber AW, Knez A, Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography—a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147-154.

27 Caussin C, Ohanessian A, Ghostine S, et al. Characterization of vulnerable nonstenotic plaque with 16-slice computed tomography compared with intravascular ultrasound. Am J Cardiol. 2004;94:99-104.

28 Rubinshtein R, Gaspar T, Halon DA, et al. Prevalence and extent of obstructive coronary artery disease in patients with zero or low calcium score undergoing 64-slice cardiac multidetector computed tomography for evaluation of chest pain syndrome. Am J Cardiol. 2007;99:472-475.